Related Experiment Video
Updated: Dec 10, 2025
08:14
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
12.7K
Targeted Gene Silencing in Malignant Hematolymphoid Cells Using GapmeR
Atish Kizhakeyil1, Mobashar Hussain Urf Turabe Fazil2, Navin Kumar Verma2,3
1Lee Kong Chain School of Medicine, Nanyang Technological University, Singapore, Singapore. ATISH001@e.ntu.edu.sg.
Methods in Molecular Biology (Clifton, N.J.)
|September 1, 2020
Summary
Researchers can now easily silence genes in blood cancer cells using a novel GapmeR method. This breakthrough overcomes challenges in delivering gene-silencing molecules to hematolymphoid cells, aiding cancer research.
Area of Science:
- Molecular Biology
- Hematology
- Oncology
Background:
- Delivering antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) for gene silencing in hematolymphoid cells is challenging.
- Existing methods face limitations in efficiency and applicability to diverse cell types.
Purpose of the Study:
- To present a simple and effective protocol for gene knockdown in malignant hematolymphoid cells.
- To introduce GapmeR as a viable tool for targeted gene silencing in these cell types.
Main Methods:
- Utilized a GapmeR-based approach for gene silencing.
- Applied the protocol to malignant hematolymphoid cell lines and primary patient-derived cells.
Main Results:
- Successfully achieved targeted gene knockdown in malignant hematolymphoid cells.
- Demonstrated the protocol's applicability across a range of cell types.
Conclusions:
- The GapmeR protocol offers a straightforward solution for gene silencing in hematolymphoid malignancies.
- This method is broadly applicable to researchers working with cell lines or primary cells from patients with blood cancers.
